Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment
We observed a 69-year old man suffering from HLA B27 ankylosing spondylitis with persistent night back pain. 18F-FDG-PET/CT showed an increased metabolism at the level of the spinal space of L2-L3, L3-L4 with increased uptake compatible with spondylodiscitis. He started therapy with etanercept 50 mg...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2016-12-01
|
Series: | Reumatismo |
Subjects: | |
Online Access: | http://www.reumatismo.org/index.php/reuma/article/view/911 |
id |
doaj-f747ab7a402b45bd8a88f6200a2480a0 |
---|---|
record_format |
Article |
spelling |
doaj-f747ab7a402b45bd8a88f6200a2480a02020-11-24T23:02:41ZengPAGEPress PublicationsReumatismo0048-74492240-26832016-12-0168316316510.4081/reumatismo.2016.911724Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatmentM. Benucci0A. Damiani1A. Arena2M. Infantino3M. Manfredi4F. Li Gobbi5Rheumatology Unit, S. Giovanni di Dio Hospital, FirenzeRheumatology Unit, S. Giovanni di Dio Hospital, FirenzeNuclear Medicine Unit, New Hospital, PratoImmunology and Allergology Laboratory Unit, S. Giovanni di Dio Hospital, FirenzeImmunology and Allergology Laboratory Unit, S. Giovanni di Dio Hospital, FirenzeRheumatology Unit, S. Giovanni di Dio Hospital, FirenzeWe observed a 69-year old man suffering from HLA B27 ankylosing spondylitis with persistent night back pain. 18F-FDG-PET/CT showed an increased metabolism at the level of the spinal space of L2-L3, L3-L4 with increased uptake compatible with spondylodiscitis. He started therapy with etanercept 50 mg/week. After six months of treatment repeated testing showed no uptake of the discs and vertebral bodies.http://www.reumatismo.org/index.php/reuma/article/view/911Spondylodiscitisetanerceptankylosing spondylitis. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
M. Benucci A. Damiani A. Arena M. Infantino M. Manfredi F. Li Gobbi |
spellingShingle |
M. Benucci A. Damiani A. Arena M. Infantino M. Manfredi F. Li Gobbi Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment Reumatismo Spondylodiscitis etanercept ankylosing spondylitis. |
author_facet |
M. Benucci A. Damiani A. Arena M. Infantino M. Manfredi F. Li Gobbi |
author_sort |
M. Benucci |
title |
Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment |
title_short |
Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment |
title_full |
Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment |
title_fullStr |
Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment |
title_full_unstemmed |
Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment |
title_sort |
aseptic hla b27-positive spondylodiscitis: decreased 18f-fdg uptake after etanercept treatment |
publisher |
PAGEPress Publications |
series |
Reumatismo |
issn |
0048-7449 2240-2683 |
publishDate |
2016-12-01 |
description |
We observed a 69-year old man suffering from HLA B27 ankylosing spondylitis with persistent night back pain. 18F-FDG-PET/CT showed an increased metabolism at the level of the spinal space of L2-L3, L3-L4 with increased uptake compatible with spondylodiscitis. He started therapy with etanercept 50 mg/week. After six months of treatment repeated testing showed no uptake of the discs and vertebral bodies. |
topic |
Spondylodiscitis etanercept ankylosing spondylitis. |
url |
http://www.reumatismo.org/index.php/reuma/article/view/911 |
work_keys_str_mv |
AT mbenucci aseptichlab27positivespondylodiscitisdecreased18ffdguptakeafteretanercepttreatment AT adamiani aseptichlab27positivespondylodiscitisdecreased18ffdguptakeafteretanercepttreatment AT aarena aseptichlab27positivespondylodiscitisdecreased18ffdguptakeafteretanercepttreatment AT minfantino aseptichlab27positivespondylodiscitisdecreased18ffdguptakeafteretanercepttreatment AT mmanfredi aseptichlab27positivespondylodiscitisdecreased18ffdguptakeafteretanercepttreatment AT fligobbi aseptichlab27positivespondylodiscitisdecreased18ffdguptakeafteretanercepttreatment |
_version_ |
1725635560655028224 |